Subject has an active infection
Active infection
Has an active systemic infection
Active infection
Uncontrolled intercurrent active infection; controlled infection on long term suppressive or maintenance therapy is permissible
Active serious infection
Active infection
Evidence of active infection
Active infection =<  days prior to study entry
Patients with active infection
Recent (<  weeks) active, documented, cervical infection
Patients with active infection
DONOR: Evidence of active infection
No active or uncontrollable infection.
Active infection
Active or incompletely treated local infection at the planned treatment site(s) and/or systemic infection
Active uncontrolled infection or severe systemic infection (enrollment is possible after control of infection).
Active infection, including any active viral infection, =<  days prior to registration
DONOR: Active infection
Patients with active systemic, pulmonary, or pericardial infection
Active infection
DONOR: Active infection
Active infection
No active or uncontrollable infection
HIV infection, active Hepatitis B or C infection, or active infections requiring oral or intravenous antibiotics or that can cause a severe disease and pose a severe danger to lab personnel working on patients' blood or tissue. If positive test results are not indicative of an active infection, patients can be included.
Active infection
Active infection =<  days prior to registration
Active systemic, pulmonary, or pericardial infection
Patients with active infection
Active infection
DONOR: Evidence of active infection
Active herpes zoster infection
Active infection =<  days prior to registration
Patients with active infection
No active infection
Active systemic infection
Active infection
Active and uncontrolled infection at time of transplantation including active infection with Aspergillus or other mold, or human immunodeficiency virus (HIV) infection
Active systemic, pulmonary, or pericardial infection
Active infection at time of transplantation (including active infection with Aspergillus or other mold within  days)
Active infection at time of transplantation (including active infection with aspergillus or other mold within  days)
Current active serious infection
Patients with active systemic, pulmonary, or pericardial infection
Serious active infection
Active infection.
Patients with an active infection
Subjects with bacteremia with documented microbiological evidence of another source of infection (eg, osteomyelitis, pneumonia, skin infection, urinary tract infection, joint infection, or abdominal infection) known to be due to the same organism cultured from the blood;
Active infection
Active infection =<  days prior to registration
Active infection at time of transplantation (including active infection with Aspergillus or other mold within  days)
Active infection
Patients with active infection are ineligible
Active infection =<  days prior to registration
Active serious infection
Active urinary tract infection
Patient may have no active uncontrollable systemic infection
Active ear/sinus infection
Patients with active infection
Subjects with an active infection
They have active diarhhea.
Active infection
Active infection
Active, unresolved infection
Patients are ineligible if they have an active infection
Active infection;
Infection
Patients with an active infection.
No active systemic, pulmonary, or pericardial infection
Current systemic infection or suspicion of active bacterial infection
Active infection
Active and uncontrolled infection; patients with an active infection receiving treatment and hemodynamically stable for  hours may be entered into the study
Patient has evidence of active systemic, pulmonary, or pericardial infection.
Active unresolved infection
Active, unresolved infection
Active dental infection
Current evidence of invasive fungal infection (blood or tissue culture); patients with recent fungal infection must have a subsequent negative cultures to be eligible; known HIV (new testing not required) or evidence of active hepatitis B or C infection (with rising transaminase values)
Active serious infection
Evidence of an active pulmonary, gastrointestinal, genitourinary, or other serious infection at time of enrollment
Active infection
Known active infection, or major episode of infection within  week prior to the start of Cycle 
Serious active infection or gastrointestinal disease
Active infection\r\n* Active infection includes patients with positive blood cultures
No active infection
active urinary tract infection;
Active systemic infection
Other active disease including but not limited to ulceration of the upper gastrointestinal tract, autoimmune disease, HIV infection, active HBV and HCV infection.
Active and uncontrolled infection at time of transplantation including active infection with Aspergillus or other mold, or human immunodeficiency virus (HIV) infection
Active infection
Active systemic infection
Any evidence of serious active infection.
Known active systemic infection (Grade ?).
Active, clinically serious infection greater than CTCAE grade . Patients may be eligible upon resolution of the infection.
Acute, active infection within  days of enrollment
Patients with active lung infection or active pulmonary edema
Known active meningeal infection
Active serious infection (pulmonary infiltrates or lesions are allowed only after the appropriate diagnostic testing is negative for infection or appropriate therapy was initiated for probable infection)
Concurrent, acute, active infection, or treatment for infection, other than oral thrush or genital herpes, within  days of enrollment
Active infection
Active uncontrolled infection at time of enrollment or documented fungal infection within  months
No active infection
Active infection including cytomegalovirus
Other significant active infection.
Active urinary tract infection
Infection:\r\n* Local infection at the puncture site\r\n* Systemic infection, osteomyelitis, discitis
Active infection
Concurrent active infection
Patients with active infection at time of biopsy
No active infection
Other significant active infection.
Active infection.
Known active infection.
Infection
Active infection
Patients should not have any clinical evidence of an active infection at the time of enrollment
Patients with active pulmonary or pericardial infection
Known active infection
Evidence of active infection
Infection
Infection
A serious active infection (> grade ) within  days of enrollment
Currently active infection
Active systemic, pulmonary, or pericardial infection
Documented or suspected infection
Active infection
Serious active infection at the time of pre-study screening.
Active infection
Active infection with hepatitis A, B, or C; active infection is defined as serologic positivity and elevated liver function tests
Active infection
Have an active urinary tract infection (UTI),
Active lung infection
EXCLUSION - STUDY : Active infection
Patients with documented infection at time of enrollment
Active Infection
Active cutaneous infection or inflammation
Patients must not have an active infection
Active systemic infection
Active infection at time of transplantation (including active infection with aspergillus or other mold within  days)
Active infection.
Known human immunodeficiency virus infection, unless well controlled. Patients who are on an adequate antiviral regimen with no evidence of active infection are considered well controlled.
Clinically active infection; an active infection may alter the biodistribution of F-FLT
Evidence of active infection within  days of study enrollment
No active skin infection
Patient has systemic infection or evidence of any surgical site infection (superficial or organ space), including active urinary tract infection
Recognized concurrent active infection
Active infection
Infection is a common feature of AML; patients with active infection are permitted to enroll provided that the infection is controlled; patients with uncontrolled infection shall not be enrolled until infection is treated and brought under control
Active infection
Patients with active systemic, pulmonary, or pericardial infection
Patients that have recognized concurrent active infection
Active infection
Patient has systemic infection or evidence of any surgical site infection (superficial or organ space), including active urinary tract infection
Active infection
